Stefanadis C et al, J Am Col Cardiol 2001 April

ΔΤ - Percutanenous Coronary InterventionsΔΤ - Percutanenous Coronary Interventions

Coronary Thermography• Thermal heterogeneity exists in vivo in atherosclerotic plaque• Statins decrease thermal heterogeneity possibly by anti-

inflammatory mechanism• Thermal heterogeneity in the culprit lesion is a prognostic

factor for adverse cardiac events after percutaneous interventions

• Is thermal heterogeneity a sensitive marker for future cardiac events?

Primary end point: Death, MI, TLR in 12 months

Secondary end points:-Procedural complications-Cost effectiveness over 12 months

Stenting of culprit lesion only Stenting of culprit + non-culprit lesions

Randomization

Non-culprit lesion(s) with > 0.10OC T

Patients with ACS and multivessel disease

THERMO ACS: Culprit or Multivessel Revascularization based on

Thermography in patients with ACS

… … Thermography Beyond Coronary ArteriesThermography Beyond Coronary Arteries